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Key Role of Capsular Polysaccharide in the Induction of Systemic
Infection and Abortion by Hypervirulent Campylobacter jejuni
Abstract
Campylobacter jejuni is a zoonotic pathogen, and a hypervirulent clone, named clone SA, has recently
emerged as the predominant cause of ovine abortion in the United States. To induce abortion, orally ingested
Campylobacter must translocate across the intestinal epithelium, spread systemically in the circulation, and
reach the fetoplacental tissue. Bacterial factors involved in these steps are not well understood. C. jejuni is
known to produce capsular polysaccharide (CPS), but the specific role that CPS plays in systemic infection
and particularly abortion in animals remains to be determined. In this study, we evaluated the role of CPS in
bacteremia using a mouse model and in abortion using a pregnant guinea pig model following oral challenge.
Compared with C. jejuni NCTC 11168 and 81-176, a clone SA isolate (IA3902) resulted in significantly
higher bacterial counts and a significantly longer duration of bacteremia in mice. The loss of capsule
production via gene-specific mutagenesis in IA3902 led to the complete abolishment of bacteremia in mice
and abortion in pregnant guinea pigs, while complementation of capsule expression almost fully restored
these phenotypes. The capsule mutant strain was also impaired for survival in guinea pig sera and sheep blood.
Sequence-based analyses revealed that clone SA possesses a unique CPS locus with a mosaic structure, which
has been stably maintained in all clone SA isolates derived from various hosts and times. These findings
establish CPS as a key virulence factor for the induction of systemic infection and abortion in pregnant
animals and provide a viable candidate for the development of vaccines against hypervirulent C. jejuni.
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ABSTRACT Campylobacter jejuni is a zoonotic pathogen, and a hypervirulent clone,
named clone SA, has recently emerged as the predominant cause of ovine abortion
in the United States. To induce abortion, orally ingested Campylobacter must translo-
cate across the intestinal epithelium, spread systemically in the circulation, and
reach the fetoplacental tissue. Bacterial factors involved in these steps are not well
understood. C. jejuni is known to produce capsular polysaccharide (CPS), but the
speciﬁc role that CPS plays in systemic infection and particularly abortion in animals
remains to be determined. In this study, we evaluated the role of CPS in bacteremia
using a mouse model and in abortion using a pregnant guinea pig model following
oral challenge. Compared with C. jejuni NCTC 11168 and 81-176, a clone SA isolate
(IA3902) resulted in signiﬁcantly higher bacterial counts and a signiﬁcantly longer
duration of bacteremia in mice. The loss of capsule production via gene-speciﬁc mu-
tagenesis in IA3902 led to the complete abolishment of bacteremia in mice and
abortion in pregnant guinea pigs, while complementation of capsule expression al-
most fully restored these phenotypes. The capsule mutant strain was also impaired
for survival in guinea pig sera and sheep blood. Sequence-based analyses revealed
that clone SA possesses a unique CPS locus with a mosaic structure, which has been
stably maintained in all clone SA isolates derived from various hosts and times.
These ﬁndings establish CPS as a key virulence factor for the induction of systemic
infection and abortion in pregnant animals and provide a viable candidate for the
development of vaccines against hypervirulent C. jejuni.
KEYWORDS Campylobacter, capsule, systemic infection, abortion, sheep, bacteremia
As a zoonotic pathogen, Campylobacter is a leading cause of bacterial foodbornegastroenteritis in humans (1). In addition, Campylobacter species have been rec-
ognized as one of the most common causes of ovine abortion in the United States and
worldwide, with an overall abortion rate of 5 to 50% in affected ﬂocks (2). As a
consequence, Campylobacter poses a signiﬁcant economic burden on sheep producers
and greatly impacts sheep health and welfare. A national study, NAHMS Sheep 2001,
conducted by the USDA/APHIS/Veterinary Services in collaboration with the American
Sheep Industry Association revealed that Campylobacter species ranked ﬁrst among all
infectious causes of abortion within the last 3 years of the study, with 53.7% of the
reported cases being conﬁrmed by a veterinarian or diagnostic laboratory (3).
Historically, Campylobacter fetus subsp. fetus accounted for the majority of the
Campylobacter spp. associated with ovine abortion; however, we recently discovered a
remarkable shift in the etiology of the disease (4, 5). Speciﬁcally, a highly virulent
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Campylobacter jejuni clone (clone SA for sheep abortion) has replaced C. fetus subsp.
fetus as the predominant cause of ovine abortion outbreaks in the United States.
Considering the high genetic diversity of Campylobacter species and the strains re-
sponsible for sheep abortion in the United States prior to the predominance of the SA
clone (5–8), this ﬁnding was unexpected and indicates that clone SA has evolved to
possess novel virulence traits that may have been favored or selected by current
agricultural practices in sheep production. In contrast, Campylobacter isolates from
sheep abortions in Great Britain and New Zealand remain genetically diverse and
comprise both species (predominantly C. fetus subsp. fetus) (5, 9). The hypervirulence of
clone SA in the induction of abortion was conﬁrmed in a pregnant guinea pig model,
in which it showed a distinct abortifacient ability compared with other C. jejuni strains
(10). Additionally, C. jejuni clone SA is zoonotic and has been implicated in a number of
human foodborne gastroenteritis cases in the United States, most of which were linked
to the consumption of raw milk (11).
Campylobacter species usually live as commensals in the intestines and gallbladder
of healthy sheep without causing clinical disease (6–8). However, highly virulent C.
jejuni strains, such as clone SA, can cause systemic infections. In susceptible pregnant
ewes, initial ingestion of C. jejuni is believed to be followed by intestinal invasion and
bacteremia with subsequent placentitis, fetal infection, and abortion (2). The ability of
this organism to induce bacteremia is believed to be one of the key elements in the
abortion process. To become bacteremic, C. jejuni must ﬁrst penetrate the intestinal
mucus layer, invade the mucosal epithelium, enter the vasculature, and surpass host
immune responses in the blood long enough to survive and spread systemically. Clone
SA is highly abortifacient in both sheep and the pregnant guinea pig model; therefore,
it must possess distinctive virulence characteristics enabling it to invade the host
intestine and bloodstream.
Despite the global importance of Campylobacter as a zoonotic pathogen and recent
advancements in our understanding of its pathogenesis (1, 12–14), little is known about
the molecular mechanisms responsible for Campylobacter-associated abortion. Previous
research on Campylobacter pathogenesis primarily focused on factors involved in
enteric infection (13, 15–17); however, systemic infection (such as bacteremia and
abortion) requires virulence factors that function beyond intestinal colonization. Al-
though the S-layer protein is a known virulence factor for C. fetus subsp. fetus-induced
abortion (18), C. jejuni does not have the S-layer protein, and how it causes abortion is
essentially unknown. To start to address these questions, we recently employed a
multiomics approach in an effort to decipher the molecular mechanism underlying the
hypervirulence of C. jejuni clone SA in systemic spread and the induction of sheep
abortion (19). The genome of a representative clone SA isolate (IA3902) was found to
be strikingly syntenic and homologous to that of C. jejuni NCTC 11168, which, despite
being able to colonize the intestine, failed to induce abortion in pregnant guinea pigs
(10). However, a closer examination indicated the presence of 12 variable regions (VRs)
between the two genomes, with the capsular polysaccharide (CPS) biosynthesis locus
being the most divergent region (14 of the 22 IA3902 genes have no homologs in NCTC
11168) (19). Interestingly, this divergent region in the CPS locus of IA3902 has very close
homology to those of three other strains (C. jejuni subsp. doylei 269.97, C. jejuni G1, and
C. jejuni strain X) that were associated with systemic infection, bacteremia, and severe
bloody diarrhea (19, 20), suggesting the existence of a link between a particular
capsular structure and the disease phenotype. This possibility was further substantiated
by the observation that C. jejuni isolates belonging to clone SA had a homogenous CPS
structure, as suggested by DNA microarray analysis of sheep abortion strains (5).
Surface polysaccharides represent the predominant structures on the outermost
layer of the cell of many bacterial species, and they are often important in interactions
between pathogens, their hosts, and the environment (21, 22). C. jejuni produces a
phase-variable CPS, which is known to be highly variable and immunogenic and serves
as the major determinant of Penner serotypes of this bacterium (21, 23–25). Currently,
there are 47 recognized Penner or heat-stable serotypes of C. jejuni, with some forming
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related serotype complexes (26, 27). CPS is one of the few clearly deﬁned virulence
factors of C. jejuni and has been shown to be involved in diarrheal disease in ferrets,
commensal colonization in chickens and mice, killing of larvae of wax moths, in vitro
adherence to/invasion of human epithelial cells, modulation of host immune responses,
and resistance to killing by serum/complement (22, 28–32). Indirect evidence for the
role of capsule in gastrointestinal disease has been demonstrated in a vaccination study
with nonhuman primates, in which a capsule conjugate vaccine was found to be highly
protective against oral C. jejuni challenge in monkeys (33). Despite these advances, the
exact role that CPS plays in the disease pathogenesis of C. jejuni still remains incom-
pletely understood (22). In particular, little is known regarding the role of CPS in the
development of bacteremia and systemic infection by C. jejuni. The availability of a
highly pathogenic C. jejuni clone with a reliable animal model provided us with an
unprecedented opportunity to address this question. In this study, the contribution of
capsule to systemic infection caused by C. jejuni clone SA was evaluated by using a
mouse model of bacteremia and a pregnant guinea pig model of fetal abortion.
RESULTS
C. jejuni IA3902 induces bacteremia in mice. Separate groups of CD-1 mice
(5/group) were orally challenged with 1 108 CFU of C. jejuni IA3902, NCTC 11168, and
81-176. One hour, 8 h, 12 h, 24 h, and 48 h after oral inoculation, cardiac blood and liver
tissues were cultured for C. jejuni. As shown in Fig. 1, bacteremia and liver infection
occurred quickly after oral inoculation, but the three C. jejuni strains showed differences
in pathogenicity. IA3902 was the most bacteremic (P  0.05), and NCTC 11168 was the
least bacteremic, with no isolation of bacteria from either blood or liver. Strain 81-176
caused only transient infection, and the bacterial titers were much lower than those of
IA3902 in both blood and liver (Fig. 1). For all three groups, the infected mice did not
appear ill or show any clinical symptoms of infection. Animals challenged with IA3902
and 81-176 were bacteremic within 1 h after dosing. For IA3902, the bacterial burden
persisted through 48 h, at which time the experiment was terminated. Quantitative
cultures of IA3902 in the blood and livers of orally infected mice did not show any
signiﬁcant differences (P  0.05) (Fig. 1). These results indicated that compared to
81-176 and NCTC 11168, clone SA possesses a remarkably increased ability to induce
bacteremia in mice.
Capsule is necessary for bacteremia in mice. We hypothesized that capsule is
important for systemic infection and that the loss of capsule would make C. jejuni clone
SA unable to induce bacteremia. To test this hypothesis, we generated a mutant strain
(ΔkpsS) that was deﬁcient in capsule production (Fig. 2) and evaluated this mutant
strain along with its parent strain (IA3902) and the genetic complement (ΔkpsS-C) in the
mouse model. As shown in Fig. 2, the ΔkpsS strain lost capsule, while the ΔkpsS-C strain
restored the production of capsule to the wild-type level. Three groups of CD-1 mice
(n  8/group) were orally challenged with the ΔkpsS, ΔkpsS-C, and IA3902 strains,
respectively. At 1, 8, and 12 h postinoculation (p.i.), cardiac blood and liver tissues were
collected for bacterial culture and CFU counts. The ΔkpsS mutant completely lost its
ability to induce bacteremia and liver infection, while the complemented strain
(ΔkpsS-C) restored virulence to near-wild-type levels (Fig. 3). This result indicates that
capsule is required for the induction of bacteremia.
Capsule is required for induction of abortion in pregnant guinea pigs. Next, we
examined the role of capsule in abortion induction using an established pregnant
guinea pig model (10, 34). Animals were conﬁrmed to be free of Campylobacter by
culturing of rectal swabs before inoculation. All of the pregnant guinea pigs (n  10)
orally inoculated with C. jejuni IA3902 aborted, with the ﬁrst abortion occurring on day
4 p.i. (Fig. 4A). The majority of abortions (n  7) occurred within the next 3 days (5 to
7 days p.i.), while the remaining two took place on days 9 and 11 p.i., respectively. In
contrast, none of the pregnant guinea pigs (n  8; 2 animals that had no identiﬁable
pregnancy at ultrasound preinoculation were found to be nonpregnant at necropsy
and were excluded from the calculations) orally challenged with the ΔkpsS isogenic
Role of Capsule in Campylobacter Pathogenesis Infection and Immunity
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capsule mutant aborted for the entire period of the study (Fig. 4A). The complemented
strain (ΔkpsS-C) induced abortion in 8 of the 9 inoculated pregnant guinea pigs starting
as early as day 4 p.i. (Fig. 4A). Pregnant animals in the control group inoculated with
NCTC 11168 did not have any abortion during the entire experiment (results not
shown). The abortion rates for the groups inoculated with IA3902 (100%) and the
ΔkpsS-C strain (88.8%) were not signiﬁcantly different (P  0.05) but were signiﬁcantly
higher (P  0.05) than that for the group inoculated with the ΔkpsS strain (0%).
Semiquantitative culture results indicated the recovery of high numbers of Campy-
lobacter cells (over 1,000 CFU on culture plates) from the majority of uteruses and
placentas of the aborted guinea pigs inoculated with IA3902 or the ΔkpsS-C strain.
Moderate levels (500 to 1,000 CFU on culture plates) of Campylobacter bacteria were
also recovered from maternal blood, whereas the numbers of bacteria cultured from
maternal intestinal contents and bile as well as fetal lung/liver were low (less than 500
CFU). In contrast, none of the samples (including the intestinal contents) from the
pregnant guinea pigs inoculated with the ΔkpsS strain yielded any Campylobacter
growth, consistent with the lack of clinical abortion in this group. It should be pointed
out that the capsule mutant exhibited growth (as determined by colony size, CFU
counts, and optical density at 600 nm [OD600] measurements for 48 h) and motility (as
FIG 1 Quantitation of systemic infection by IA3902, 81-176, and NCTC 11168 in CD-1 mice. Mice were orally
challenged with 108 CFU of each strain. At each time point, 5 mice were sacriﬁced, and the numbers of C.
jejuni bacteria in cardiac blood (A) and liver tissue (B) were determined. Each bar represents the log10 CFU
per milliliter of blood or gram of liver (means  SEM) for 5 mice. *, P  0.05 (statistically signiﬁcant). Data
were collected in three different trials, which were performed under similar conditions.
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determined on motility agar) in culture media comparable to those of the wild-type
strain (data not shown). Thus, the lack of infection in animals was not due to a growth
or motility defect. The culture results (i.e., percentage of positive samples from preg-
nant animals among groups) are summarized in Fig. 4B. Histological examination
FIG 2 Analysis of capsule expression of C. jejuni IA3902 with alcian blue staining. Lanes: 1, wild-type strain
IA3902; 2, capsule mutant strain (ΔkpsS); 3, complemented mutant strain (ΔkpsS-C). Positions of capsule
(CPS) and lipooligosaccharide (LOS) are shown.
FIG 3 Effect of CPS on systemic infection of mice by C. jejuni. CD-1 mice (n  8/group) were challenged
via gastric gavage with 108 CFU of either wild-type strain IA3902 or the ΔkpsS or ΔkpsS-C mutant, and
CFU were determined at different time points. Each bar represents the log10 CFU per milliliter of blood
(A) or gram of liver (B) (means SEM) for 5 mice. *, P 0.05 (statistically signiﬁcant). Data were collected
in two different trials, which were performed under similar conditions.
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revealed that the uteruses and placentas from the aborted guinea pigs inoculated with
IA3902 or the ΔkpsS-C strain produced prominent microscopic inﬂammatory lesions,
whereas those from animals inoculated with the ΔkpsS strain had no obvious micro-
scopic lesions. Microscopic uterine lesions included suppurative endometritis, metritis,
edema, and hemorrhage of various severities. Microscopic placental lesions included a
combination of hemorrhage, necrosuppurative inﬂammation, and necrosis. These
changes were evident on both the maternal and fetal sides of the placenta (results not
shown). Nonpregnant guinea pigs and nonaborted pregnant animals were all Campy-
lobacter negative upon culture and did not manifest any pathological ﬁndings on
histopathology.
Capsule contributes to resistance to serum bactericidal activity. Survival in
blood is a key pathogenic step for the systemic spread of Campylobacter during
abortion induction. To examine if capsule was involved in resistance to the bactericidal
activity of serum, C. jejuni IA3902, its isogenic capsule mutant (ΔkpsS), and the com-
plemented strain (ΔkpsS-C) were treated with fresh (containing complement activity)
guinea pig serum free of Campylobacter-speciﬁc antibody. Following 2 h of incubation
with serum, the capsule mutant showed a reduction in CFU counts of approximately 2.5
log10 units compared to the numbers at 0 h (Fig. 5A). This difference in CFU was
FIG 4 (A) Abortion rates following oral inoculation with the C. jejuni IA3902 wild-type, capsule mutant
(ΔkpsS), and complemented capsule mutant (ΔkpsS-C) strains in pregnant guinea pigs. (B) Percentages of
culture-positive pregnant guinea pigs (n  10, 8, and 9 in the wild-type, mutant, and complemented
groups, respectively) by each sample type processed at necropsy following abortion or at termination of
the experiment 21 days after oral inoculation with the C. jejuni IA3902 wild-type, capsule mutant (ΔkpsS),
or complemented capsule mutant (ΔkpsS-C) strain.
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statistically signiﬁcant (P  0.05). In contrast, the wild-type strain led to only a marginal
reduction in bacterial counts upon treatment with guinea pig serum (P  0.05).
Additionally, the ΔkpsS-C strain fully restored the serum resistance level to that of the
wild-type isolate (Fig. 5A). Serum sensitivity analysis was also performed by using fresh
whole sheep blood, which revealed that the ΔkpsS mutant strain was no longer
recoverable after 4 h of incubation in sheep blood, while the wild-type and ΔkpsS-C
strains showed only modest reductions in CFU counts, and this reduction was not
signiﬁcant (P  0.05) compared to values at time zero (Fig. 5B). These results indicated
that capsule production is required for the optimal survival of C. jejuni within guinea pig
serum and sheep blood.
Characteristics of the CPS locus of C. jejuni clone SA. (i) Genetic features. The
complete genome sequence of IA3902 (a clone SA isolate), including the entire CPS
locus, was reported previously (19). Similar to other C. jejuni CPS loci studied so far, the
capsular locus of IA3902 is organized into three regions in which the variable biosyn-
thetic region is ﬂanked by the conserved regions responsible for capsule transport and
assembly (20, 22, 35, 36). The biosynthetic CPS locus of IA3902 (located between kpsC
and kpsF, excluding these two genes) is approximately 26.4 kb long and comprises 22
genes of various predicted functions involved in capsule synthesis and modiﬁcation
(Table 1). Most of the predicted proteins encoded by the genes in the biosynthetic CPS
locus of IA3902 exhibit high homology (over 85% amino acid identity) to at least one
other counterpart in CPS loci from different C. jejuni strains (Table 1). As with many
other biosynthetic CPS loci in C. jejuni, the four conserved genes (CJSA_1346 to
CJSA_1349) involved in the biosynthesis of phosphoramidate (MeOPN) are present in
IA3902, indicating the likelihood of this modiﬁcation in IA3902. Although the CPS locus
of IA3902 harbors a gene (gmhB) involved in the heptose pathway, it lacks the other
conserved genes (hddC, gmhA, and hddA) necessary for heptose biosynthesis, indicat-
ing that this strain may not be able to synthesize this structure, which is found in many
other CPS loci of C. jejuni strains (20, 22, 35). Another feature that is frequently found
among the capsules of C. jejuni strains is the presence of glycerol phosphate residues,
which are also suspected to be present in the capsule of IA3902 since the CPS locus of
this strain harbors the two genes (tagD and tagF) involved in the biosynthesis of this
structure (20, 35).
Previously, IA3902 was determined to belong to Penner serotype HS:1,8 (reacting
with HS:1 and, to a lesser extent, HS:8 antisera) (11). This is, to our knowledge, the only
C. jejuni strain with this serotype combination, suggesting the uniqueness of its CPS
structure. As shown in Table 1, the biosynthetic CPS locus of IA3902 appears to be a
mosaic of those of C. jejuni G1 (which belongs to HS:1; isolated from a patient with
Guillain-Barre syndrome) and, to a lesser extent, other strains, including C. jejuni 5070
(associated with the HS:4 Penner complex; belongs to the “hyperinvasive” sequence
FIG 5 Survival of the C. jejuni IA3902 wild-type, capsule mutant (ΔkpsS), and complemented capsule mutant (ΔkpsS-C) strains
in 20% fresh guinea pig serum (A) or in whole sheep blood (B). Data from a single experiment are shown (triplicates); similar
results were obtained from an independent experiment. Signiﬁcant differences (*, P  0.05) are indicated.
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type 677 [ST-677] clonal complex), C. jejuni subsp. doylei 269.97 (a serostrain of HS:17;
isolated from human blood), and strain X (untypeable; cultured from a human patient
with severe bloody diarrhea).
(ii) Genetic stability of the CPS locus. The ﬁndings presented above indicated the
uniqueness of the CPS locus in C. jejuni IA3902. To determine whether other clone SA
isolates possessed the same CPS genes, we carried out a sequence-based comparison
of the CPS locus of IA3902 and those of other C. jejuni strains from multiple sources,
TABLE 1 List of genes in the entire CPS locus of C. jejuni IA3902 (HS:1,8)d
Genea
Product
size (aa)e
Similarity to strain (serotype)b
Annotation
C. jejuni
G1 (HS:1)
C. jejuni
CJJ5070
(HS:4 complex)
C. jejuni subsp.
doylei 269.97
(HS:17)
C. jejuni X
(untypeable)
C. jejuni
ATCC 43436
(HS:8)
C. jejuni
NCTC 11168
(HS:2)
kpsS 394 Y Y Y Y Y Y Capsule polysaccharide export
protein KpsS
kpsC 689 Y Y Y Y Y Y Capsule polysaccharide export
protein KpsC
cysC 170 Y Y Y Y D Y Adenylyl sulfate kinase
CJSA_1347 253 Y Y Y Y N Y Putative sugar-phosphate
nucleotidyltransferase
CJSA_1348 200 Y Y Y Y N Y Putative amidotransferase
CJSA_1349 779 Y Y Y Y N Y Putative transferase
CJSA_1350 253 Y Y Y Y N Y Putative methyltransferase
CJSA_1351 257 Y Y Y Y N Y Putative methyltransferase
CJSA_1352 612 D D N D N D Putative sugar transferase
CJSA_1353 240 N Y Yc Y N N Capsular polysaccharide
biosynthesis protein
CJSA_1354 507 N Y Yc Y N N Capsular polysaccharide
biosynthesis protein
gmhB 132 N Y Yc Y N N Heptose biphosphate
phosphatase
CJSA_1356 639 N N N Y D N Putative capsular polysaccharide
biosynthesis protein
CJSA_1357 619 N N N N N N Putative sugar
nucleotidyltransferase
CJSA_1358 109 N Y Yc N N N Conserved hypothetical protein
CJSA_1359 111 N Y Yc N N N Conserved hypothetical protein
CJSA_1360 241 N Y Yc N N N Putative nucleotidyltransferase
CJSA_1361 212 N Y Yc N N N HADf superfamily hydrolase
CJSA_1362 212 N Y Yc N N N Conserved hypothetical protein
CJSA_1363 637 Y N N N N D Putative sugar transferase
CJSA_1364 851 Y N N N N N Putative sugar transferase
tagF 1,095 Y N N D D N Putative CDP glycerol
glycerophosphotransferase
TagF
CJSA_1366 402 Y N N Y Y N Conserved hypothetical protein
tagD 129 Y N N Y Y N Putative glycerol-3-phosphate
cytidylyltransferase TagD
kpsF 315 Y Y Y Y Y Y Arabinose 5-phosphate
isomerase
kpsD 552 Y Y Y Y Y Y Capsular polysaccharide ABC
transporter KpsD
kpsE 372 Y Y Y Y Y Y Capsular polysaccharide ABC
transporter KpsE
kpsT 220 Y Y Y Y Y Y Capsular polysaccharide ABC
transporter KpsT
kpsM 260 Y Y Y Y Y Y Capsular polysaccharide ABC
transporter KpsM
aBased on the gene name/locus tag of the sequenced genome of C. jejuni IA3902 (GenBank accession no. CP001876.1).
bY, yes (present with over 85% identity at the amino acid level); D, divergent (present with less than 85% identity); N, no (not present).
cThese genes are located in tandem as a separate cluster outside the CPS locus in this strain.
dThe entire CPS cluster of IA3902 is virtually identical to that of C. jejuni PT14 (NCBI GenBank accession no. NC_018709.2) and highly homologous to that of C. jejuni
01/51 (NCBI GenBank accession no. ERS742291 and ERS742289). Thus, these two strains are not included in the table.
eaa, amino acids.
fHAD, haloacid dehalogenase.
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including clone SA isolates from sheep (Table 2). Of note, the CPS sequences of these
strains were previously determined to a near-complete stage with paired-end reads (2
by 100 bp) on an Illumina HiSeq 2000 machine (37). The results showed that all the
sequenced clone SA isolates (n  63) had nucleotide sequences in their CPS loci that
were virtually identical to that of IA3902 regardless of their isolation sources (sheep
abortion, bovine abortion, goat abortion, sheep feces/bile, chicken feces, and human
gastroenteritis) or years (1991 to 2013) (Table 2). This ﬁnding indicates that the CPS
locus in clone SA is genetically stable.
Production of capsule. To examine the production of capsule in clone SA isolates
from sheep abortions, proteinase-treated whole-cell extracts were separated on a
Tricine SDS-PAGE gel and stained with alcian blue as described previously (23). As
shown in Fig. 6, all six clone SA strains produced an intense capsule band, the size and
intensity of which are different from those of other strains of different genotypes,
suggesting the presence of a distinct capsular structure in C. jejuni clone SA.
DISCUSSION
This study provides the ﬁrst direct experimental evidence for a role of capsule in the
pathogenesis of bacteremia, systemic infection, and abortion caused by a hypervirulent
C. jejuni clone. Although C. jejuni is mainly considered a gastrointestinal pathogen in
humans, it can occasionally cause severe conditions, including neurological complica-
tions (e.g., Guillain-Barre and Miller Fisher syndromes), bacteremia, and systemic infec-
tions such as abortion and newborn meningitis (38, 39). In ruminants, C. jejuni is
becoming an important etiological factor for abortion. However, bacterial factors
involved in the pathogenesis of extraintestinal infections due to C. jejuni are under-
studied. Even though the capsule of C. jejuni was presumed to play a crucial role in
TABLE 2 Sequence-based comparison of CPS loci among C. jejuni strains in reference to clone SA isolate IA3902a
Group
No. of
isolates
Yr of
isolation Source ST(s) CC(s) Description
Reference
IA3902 1 2006 Sheep abortion 8 21 Penner serotype HS:1,8; whole genome
sequenced
Clone SA
Early-SA 11 1991–1993 Sheep abortion 8 21 CPS locus identical to that of IA3902
Mid-SA 3 1999–2000 Sheep abortion 8 21 CPS locus identical to that of IA3902
Recent-SA 27 2003–2013 Sheep abortion 8 21 CPS locus identical to that of IA3902
Bovine-SA 5 2003–2009 Bovine abortion 8 21 CPS locus identical to that of IA3902
Goat-SA 4 2005–2010 Goat abortion 8 21 CPS locus identical to that of IA3902
Sheep-SA 4 2008 Sheep feces/bile 8 21 CPS locus identical to that of IA3902
Bird-SA 2 2004 Chicken feces 8 21 CPS locus identical to that of IA3902
Human-SA 7 2003–2010 Human enteritis 8 21 CPS locus identical to that of IA3902
Non-clone SA
Early-U.S. 1 1993 Sheep abortion 21 21 Rare; predicted progenitor of clone SA;
CPS locus identical to that of IA3902
Early-U.S. 1 1993 Sheep abortion 441 UA Rare, CPS locus divergent from that of
IA3902
Early/mid-U.S. 6 1993–2004 Sheep abortion 50 21 Rare; 4 are identical to IA3902; 2 are
divergent from IA3902
Recent-U.S. 10 2003–2010 Sheep abortion 38, 42, 43, 45, 607,
806, 982, 5189
48, 42, 21, 45,
607, 61
CPS locus divergent from that of
IA3902
U.K. 9 2003–2008 Sheep abortion
from U.K.
21, 42, 45, 50, 206,
227, 270
21, 42, 45,
206, 403
CPS locus divergent from that of
IA3902, except ST-50
Other
Cont-1 1 1985 Human enteritis 43 21 NCTC 11168; divergent;
nonabortifacient in guinea pigs
Cont-2 1 2006 Sheep feces 61 61 OF48; divergent; nonabortifacient in
guinea pigs
aST, sequence type; CC, clonal complex; UA, unassigned.
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systemic disease due to its involvement in resistance to serum killing and phago-
cytosis as determined by in vitro studies (22, 32, 40), direct in vivo evidence for its
contribution to the induction of bacteremia and systemic infection had not been
demonstrated prior to this study. Here, we provide compelling evidence demon-
strating that capsule is a key virulence determinant in a highly pathogenic C. jejuni
clone (clone SA) using two different animal models, i.e., mouse bacteremia and
guinea pig abortion. In both models, the capsule mutant showed a severe pheno-
typic defect, while complementation of the mutant restored its ability to induce
bacteremia and abortion (Fig. 3 and 4).
There are several possible mechanisms underlying how capsule may contribute to
systemic infection and abortion. Results from this study suggest that capsule plays a
role in the survival and persistence of C. jejuni in the bloodstream and subsequent
fetoplacental invasion, since the noncapsular mutant displayed a clear defect in serum
resistance, bacteremia, and abortion induction (Fig. 3 to 5). Additionally, data from this
study suggest a role of capsule in the colonization and/or translocation of intestinal
mucosa and entering the bloodstream, as the noncapsular C. jejuni mutant was not
recovered from any site, including cecal contents, bile, heart blood, uterus, and
placenta, in pregnant guinea pigs (Fig. 4B). This notion is supported by ﬁndings from
previous studies in which the capsule of C. jejuni was shown to play an important role
in adhesion to/invasion of intestinal epithelial cells in vitro, colonization of chickens and
mice, and induction of diarrhea in ferrets (29, 31, 40–42). The lack of capsule in C. jejuni
was also associated with increased cytokine production by murine dendritic cells in
vitro (43) and by lamina propria CD4 T cells from mouse intestine (31), which play an
important role in the innate immune response to enteric bacterial pathogens (44, 45),
suggesting the involvement of capsule in protection against the induction of immune
responses in the gut. Altogether, these results demonstrate the signiﬁcance of capsule
in the evasion of host innate immunity present in the gut mucosa and systemic
circulation by a hypervirulent C. jejuni clone.
It is most likely that the presence of a functional capsule, regardless of its structure,
is required for systemic infection and abortion induction. This notion is supported by
ﬁndings from a very recent study (37), which identiﬁed the key role of speciﬁc
mutations in porA, encoding the major outer membrane protein (MOMP), in abortion
induction by C. jejuni clone SA. Speciﬁcally, transferring speciﬁc mutations in porA of C.
jejuni IA3902 (HS:1,8) to NCTC 11168 (HS:2), a nonabortifacient strain, converted it into
a fully virulent strain (37), despite the fact that IA3902 and NCTC 11168 have different
CPS sequences (Table 1). These ﬁndings indicate that the function of CPS is required but
is not sufﬁcient for abortion induction. The genetic and structural variations of CPS may
contribute to other phenotypes such as antigenic variation and immune evasion, which
remain to be determined in future studies.
FIG 6 Capsule of C. jejuni as detected by Tricine SDS-PAGE with alcian blue staining. Clone SA isolates
of sheep abortions from Iowa (lanes 3 and 4), South Dakota (lanes 5 and 6), and Idaho (lanes 7 and 8)
are depicted. As controls for non-clone SA isolates, NCTC 11168 (lane 1), 81-176 (lane 2), and OF48 (lane
9) (from feces of healthy sheep) are included. M, prestained protein size markers (Bio-Rad). Positions of
CPS and lipooligosaccharide (LOS) are shown on the right.
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Both sequence-based comparisons and phenotypic analysis (Table 2 and Fig. 6)
indicated the presence of a unique CPS structure possessed by clone SA isolates.
Considering the overall diversity of capsule loci detected among C. jejuni strains (20,
27), it is quite remarkable that all clone SA isolates had almost identical CPS sequences
regardless of the time (spanning over 20 years), host (sheep, cattle, goat, chicken, and
human), or site (aborted materials, feces, and bile) of isolation. In contrast to our
ﬁndings, a recent study analyzing the CPS loci of hyperinvasive C. jejuni strains
discovered a high degree of variability in capsule locus architectures even among
strains that were very similar on the genome level (46). More speciﬁcally, among the six
hyperinvasive strains studied, four of them were identical at the level of the core
genome phylogeny (all belonging to ST-21) but had substantial genetic diversity in the
capsule loci (46). The localized variations in the capsule loci of otherwise clonal strains
are likely due to horizontal gene transfer and homologous recombination, which were
reported in previous studies (20, 35). The high stability of the capsule locus in clone SA
isolates over the years suggests that it is necessary for the adaptation of clone SA in the
ruminant reservoir.
In agreement with the high degree of genetic similarity, phenotypic analysis with
alcian blue staining also suggested the presence of stable and similar CPS structures
among the different isolates of clone SA (Fig. 6). Different levels of intensity of CPS
shown with alcian blue (a cationic dye) staining were previously observed (23), and it
was suggested that high intensity was associated with the presence of glycerol
phosphate residues (negatively charged) in the CPSs of certain C. jejuni isolates (20). The
intensive staining of the CPSs of clone SA isolates is consistent with the fact that clone
SA contains the tagD and tagF genes responsible for the biosynthesis of glycerol
phosphate (Table 1). It should be pointed out that alcian blue also stains capsules that
lack glycerol phosphate but contain MeOPN (also negatively charged), as was the case
with strains 11168 and 81-176 (Fig. 6).
Ovine abortion poses a major economic burden on sheep producers worldwide, and
C. jejuni clone SA has been consistently the predominant cause of this important
disease in the United States for over a decade (4, 5). Whole-cell-based killed vaccines
(along with antibiotics) have been used for the control of Campylobacter-associated
abortions in sheep; however, their efﬁcacy appears to be poor and varies widely in the
United States (47, 48). Previous studies indicated that CPS is a protective antigen, as
capsule is a proven virulence determinant of C. jejuni, and a capsule-based conjugate
vaccine was highly immunogenic and protective against disease in both mice and
monkeys (33, 49). Considering the ﬁndings of this study showing that the CPS is a
crucial virulence factor in systemic infection (Fig. 3 and 4) and is highly conserved and
stable over time (Table 2), capsule may be used as a potential target for the develop-
ment of an efﬁcacious vaccine to prevent sheep abortion in the United States.
In summary, our results demonstrate that capsule plays an indispensable role in the
pathogenesis of bacteremia and fetoplacental infection, the hallmarks of hypervirulent
C. jejuni clone SA that has emerged during the last decade as the predominant cause
of sheep abortion in the United States. We showed that the isogenic acapsular IA3902
mutant was totally attenuated in the induction of bacteremia in the mouse model and
of abortion in the pregnant guinea pig model, which correlated with its impaired
survival in serum and whole blood. We further identiﬁed that the CPS locus of IA3902
has a mosaic organization and contains several genes that are common to other
Campylobacter strains with perceived high virulence. The CPS locus of clone SA was
found to be strikingly stable, as all the strains of this clone had virtually identical capsule
sequences regardless of the time or source of isolation, suggesting a role for capsule in
bacterial persistence and ﬁtness. Altogether, these ﬁndings establish the capsule as a
feasible candidate for the development of effective antibacterial means against sys-
temic infections associated with C. jejuni, a zoonotic pathogen causing disease in both
humans and animals worldwide.
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MATERIALS AND METHODS
Bacterial strains and growth conditions. C. jejuni IA3902 is a clinical isolate of clone SA originally
derived from an ovine abortion case in Iowa in 2006, as described previously (4). The complete genome
of IA3902 has been sequenced (19). C. jejuni NCTC 11168 and 81-176 are both human isolates (25, 50),
nonabortifacient, and genome sequenced and were used as controls. All C. jejuni strains were grown on
Mueller-Hinton (MH) agar under microaerobic (5% oxygen, 10% carbon dioxide, and 85% nitrogen)
conditions at 42°C for up to 48 h. When needed, the culture medium was supplemented with
Campylobacter-selective agents and supplements (catalog no. SR084E and SR117E; Oxoid). Kanamycin
(50 g/ml) or chloramphenicol (20 g/ml) was added to MH medium as needed.
Construction of a CPS mutant. Insertion-deletion mutagenesis in the kpsS gene (encoding an ABC
transporter involved in capsule transport) of IA3902 was performed in order to deﬁne the role of CPS in
studies performed here according to our previously reported methods (51). Brieﬂy, a 1,693-bp region
harboring kpsS (CJSA_1344) (1,182 bp) of IA3902 was PCR ampliﬁed with primers kpsS_F and kpsS_R
(Table 3) and cloned into the commercial vector pGEM-T (Promega, Madison, WI) to yield pGEM-T::kpsS.
The resulting construct was digested with SwaI and ligated with the aphA-3 gene that was ampliﬁed from
pMW10 (52) with primers Kan_F and Kan_R (Table 3). The suicide vector was delivered to C. jejuni IA3902
via natural transformation, and mutants were selected on MH agar plates containing kanamycin (50
g/ml). ΔkpsS mutants were conﬁrmed by PCR analysis and alcian blue staining (Fig. 2), as described
below.
Complementation of the kpsS mutant in trans. The construction of the complementing plasmid
for the kpsS mutant was based on methods reported in our previous study (53). The entire coding region
of the kpsS gene was ampliﬁed from strain IA3902 by PCR using primers ST101_F and ST101_R (Table 3).
The PCR product was digested with SacI and SacII and cloned into the plasmid construct pRY112-pABC
(54, 55) to generate pRY112-kpsS, in which the kpsS gene was fused to the constitutively expressed
promoter of cmeABC. The constructed plasmid was conﬁrmed by PCR. For complementation, the shuttle
plasmid pRY112-kpsS was introduced into the ΔkpsS mutant by conjugation. The complemented strain
was selected on MH agar containing chloramphenicol (20 g/ml) and named the ΔkpsS-C strain. PCR
analysis and alcian blue staining were performed to conﬁrm the complementation of capsule expression
(Fig. 2). Both the ΔkpsS and ΔkpsS-C mutant strains grew on nonselective and Campylobacter-selective
agar plates comparably to the wild type, and each strain exhibited wild-type levels of motility (results not
shown).
Alcian blue staining for CPS. Preparation of CPS samples for alcian blue staining was performed as
previously described (23). Wild-type and mutant C. jejuni cells were harvested following 24 h of growth
on MH agar, weighed, and solubilized in 300 l of lysis buffer (2% sodium dodecyl sulfate, 4%
2-mercaptoethanol, 10% glycerol, 1 M Tris-HCl [pH 6.8], and 10 mg bromophenol blue) for 10 min at
100°C. After centrifugation at 13,000  g for 5 min, 20-l aliquots were taken, mixed with proteinase K
(Sigma, St. Louis, MO) to a ﬁnal concentration of 1 g/l, incubated at 50°C for 1 h, and fractionated by
SDS-PAGE. CPS was visualized by alcian blue staining (0.1% alcian blue dye, 40% ethanol, and 5% acetic
acid).
Mouse experiments. Eight- to ten-week-old wild-type CD-1 (outbred) female mice were purchased
from Charles River Laboratories (Wilmington, MA) and maintained by Laboratory Animal Resources at
Iowa State University. The mice were housed for a minimum of 3 days before being used for experiments.
Following oral inoculation, mice were housed in groups of four or ﬁve in sterile polycarbonate microiso-
lator cages with autoclaved bedding and provided with water and feed ad libitum (except that feed was
withdrawn overnight prior to bacterial challenge). C. jejuni bacteria used for inoculations were recovered
from freezer stocks, plated onto selective medium, and incubated for 48 h microaerobically. Bacterial
cultures obtained from these plates were subpassaged under the same conditions for 18 to 20 h. Fresh
cultures were harvested and suspended in MH broth, diluted to the desired concentration based on the
optical density, and subsequently conﬁrmed by viable plate counts. Each mouse received 100 l bacterial
culture (approximately 1  108 CFU) via gastric gavage using a curved, ball-tipped, 18-gauge, 2-inch
needle under light sedation with 2% isoﬂurane, as previously described (56).
At 1, 8, 12, 24, and 48 h p.i., mice were deeply anesthetized via intraperitoneal (i.p.) injection of a
ketamine-xylazine mixture, followed by exsanguination. Samples harvested for Campylobacter culture
included cardiac blood and liver. Blood was collected by the use of a sterile tuberculin syringe with a
22-gauge needle and placed into blood collection tubes (0.5-ml Greiner Vacuette MiniCollect K3 EDTA;
Fisher Scientiﬁc). Within 2 h of sample collection, 250 l of undiluted blood and appropriate serial
dilutions were plated onto Campylobacter-selective medium and incubated for 48 h. Since liver has a
potential role in clearing C. jejuni from the bloodstream, liver tissues were also cultured. Liver tissues were
TABLE 3 PCR primers used in this study
Primer Sequence (5=–3=)a
kpsS_F GCT CAA GTT GAA GAT GAT GCT TCG ATG AT
kpsS_R CAT ACC AAA ACA GGA TTG GGT TTA TAA GCA TGA
kan_R CTT ATC AAT ATA TCC ATG GAA TGG GCA AAG CAT
kan_F GAT AGA ACC ATG GAT AAT GCT AAG ACA ATC ACT AAA
ST101_F TAG CCG CGG AAA CTT TTA TGC TTA GAA AAA T
ST101_R CTA GAG CTC TTA GGA TCA TAT CCT GCT ATA T
aThe underlined sequences indicate the restriction sites for SacI (GAGCTC) and SacII (CCGCGG).
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placed into a separate sterile plastic bag (Whirl-Pak; Nasco, Fort Atkinson, WI), weighed, homogenized in
sterile MH broth, serially diluted, plated onto selective medium, and incubated for 48 h microaerobically.
C. jejuni recovery is expressed as log10 CFU per milliliter of blood or gram of liver. Fecal swabs were taken
before challenge, and a noninoculated control group (n  5) was sacriﬁced at the ﬁnal time point (48 h)
to conﬁrm that all mice were Campylobacter free and that no cross-contamination occurred. Additionally,
recovered isolates were subjected to PCR/antibiotic susceptibility conﬁrmation to ensure that the source
of infection was oral inoculation and not environmental contamination or cross-contamination.
Pregnant guinea pig experiments. Palpably pregnant (at approximately 30 to 35 days of gestation)
Hartley guinea pigs were obtained from a commercial source (ELM Hill Labs, Chelmsford, MA) for use in
this study according to overall protocols described previously (10). Animals were housed individually in
standard plastic cages with wood chip bedding and provided with a commercial guinea pig diet and
water ad libitum, except that the feed was withdrawn overnight prior to bacterial challenge. Rectal swabs
were obtained and cultured to conﬁrm that animals were free of Campylobacter prior to experimental
inoculation. Within 48 h of housing, the animals were subjected to ultrasound to conﬁrm pregnancy. The
animals were then divided into 3 groups (each consisting of 10 subjects) and inoculated orally by
employing the same type of feeding needle as the one used on mice with a fresh culture (grown for
about 20 h on MH agar) of C. jejuni strain IA3902 (wild type), the ΔkpsSmutant (isogenic capsule mutant),
or the ΔkpsS-C strain (complemented capsule mutant strain). Each guinea pig within a group received 1
ml MH broth containing approximately 2 108 CFU of the respective strain. As a negative-control group,
5 animals were orally inoculated with C. jejuni NCTC 11168, which was shown to be nonabortifacient in
our previous study (10).
Following inoculation, the guinea pigs were monitored twice daily for signs of abortion (vaginal
bleeding and/or expelled fetuses/placentas). Once an animal was found to have signs of abortion, it was
euthanized via i.p. injection of a commercial sodium pentobarbital solution (Fatal-Plus 390 mg/ml;
Vortech Pharmaceuticals, Dearborn, MI). At necropsy, samples were collected for semiquantitative
bacterial culture (maternal blood from the heart, bile, intestinal contents, uterus, placenta, and fetal
lung/liver) and histopathology (uterus and placenta). Semiquantitative culture involved plating out
approximately 250 l of ﬂuid samples or streaking a cotton swab that had been macerated into
approximately 5 g of tissue samples over the entire surface of the agar plate. Growth was then recorded
in a “semiquantitative” fashion such that “high” designates 1,000 CFU/plate, “moderate” indicates 500
to 1,000 CFU/plate, and “low” speciﬁes 500 CFU/plate. The culture conditions for Campylobacter (the
selective media used and incubation) were the same as those described above for the mouse experi-
ments. On day 21 postinoculation, all nonaborted animals were euthanized and necropsied for culture
and histopathology as described above. The isolates recovered from the tissues were conﬁrmed to be the
inoculated strain for each group by using speciﬁc PCR and culture on antibiotic-containing media. All of
the procedures and protocols involving animal studies (both mice and guinea pigs) were approved by
the institutional animal care and use committee (IACUC) at Iowa State University prior to the start of
experiments.
Serum bactericidal assay. To determine the role of capsule in resistance to the bactericidal activity
of guinea pig serum, sera were collected from ﬁve Campylobacter-free pregnant guinea pigs, conﬁrmed
to be free of Campylobacter-speciﬁc antibodies by immunoblotting, pooled, ﬁlter sterilized with a
0.22-m ﬁlter, and kept frozen in small aliquots at 80°C until use. Bacterial inocula were prepared from
fresh cultures of C. jejuni IA3902, the ΔkpsS mutant, and the ΔkpsS-C strain grown overnight, and the
OD600 was adjusted to 0.01 to give approximately 1  107 CFU/ml of each strain. The bactericidal assay
was performed in sterile 96-well culture plates at 37°C with microaerobic incubation according to
previously described methods (32, 57). Each reaction well (3 wells per strain) was supplemented with 200
l of the pooled serum (at a ﬁnal concentration of 20% serum) and the bacterial inoculum (ﬁnal cell
concentration of approximately 5  105 CFU/ml). Bacterial counts for each strain were determined via
plate culture before (0 h) and after 2 h of incubation under the conditions described above. Log10-
converted CFU at 0 h and 2 h of incubation were used to determine the amount of killing by serum for
each strain. The experiment was repeated twice. Similar experiments were also performed with fresh
sheep blood, in which the bacterial counts were determined after incubation in whole blood for 4 h.
Genetic features and distribution of CPS in clone SA isolates. Characteristics of the CPS locus,
including genetic organization, gene content, and predicted structural modiﬁcations, were determined
by using the complete genome sequence of strain IA3902 of C. jejuni clone SA (GenBank accession no.
CP001876.1). Comparative genomic analysis of the CPS locus was carried out by utilizing the near-
complete genome sequences of a large number of clone SA isolates determined previously (37). The
distribution of the CPS loci among clone SA genomes and relevant Campylobacter strains were ascer-
tained by using the available sequence data. Alcian blue staining (23) was used to determine the overall
production/structure of the CPS of clone SA isolates and for comparison to other strains with known
phenotypes.
Statistical analysis. Systemic infection results for mice are expressed as mean log10 CFU per milliliter
of blood or gram of liver, with error bars denoting the standard errors of the means (SEM). The
signiﬁcance of differences in the levels of systemic infection between groups inoculated with different
wild-type or mutant strains was determined by using the Wilcoxon rank sum test. Statistical analysis of
serum bactericidal assay results was performed with the Student t test. Log rank and Wilcoxon rank sum
tests were used to compare abortion rates among groups of pregnant guinea pigs inoculated with
different strains. P values of less than 0.05 were considered statistically signiﬁcant for all analyses.
Role of Capsule in Campylobacter Pathogenesis Infection and Immunity
June 2017 Volume 85 Issue 6 e00001-17 iai.asm.org 13
 o
n
 N
ovem
ber 29, 2017 by IO
W
A STATE UNIVERSITY
http://iai.asm
.org/
D
ow
nloaded from
 
ACKNOWLEDGMENT
This work was supported by AFRI Animal Health competitive grant no. 2013-67015-
20368 from the USDA National Institute of Food and Agriculture.
REFERENCES
1. Kaakoush NO, Castano-Rodriguez N, Mitchell HM, Man SM. 2015. Global
epidemiology of Campylobacter infection. Clin Microbiol Rev 28:
687–720. https://doi.org/10.1128/CMR.00006-15.
2. Skirrow MB. 1994. Diseases due to Campylobacter, Helicobacter and
related bacteria. J Comp Pathol 111:113–149. https://doi.org/10.1016/
S0021-9975(05)80046-5.
3. USDA. 2001, Part II: reference of sheep health in the United States. USDA,
APHIS, VS, CEAH, National Animal Health Monitoring System, Forth
Collins, CO.
4. Sahin O, Plummer PJ, Jordan DM, Sulaj K, Pereira S, Robbe-Austerman S,
Wang L, Yaeger MJ, Hoffman LJ, Zhang Q. 2008. Emergence of a
tetracycline-resistant Campylobacter jejuni clone associated with out-
breaks of ovine abortion in the United States. J Clin Microbiol 46:
1663–1671. https://doi.org/10.1128/JCM.00031-08.
5. Wu Z, Sippy R, Sahin O, Plummer P, Vidal A, Newell D, Zhang Q. 2014.
Genetic diversity and antimicrobial susceptibility of Campylobacter jejuni
isolates associated with sheep abortion in the United States and Great
Britain. J Clin Microbiol 52:1853–1861. https://doi.org/10.1128/JCM
.00355-14.
6. Stanley K, Jones K. 2003. Cattle and sheep farms as reservoirs of Cam-
pylobacter. J Appl Microbiol 94(Suppl):104S–113S. https://doi.org/10
.1046/j.1365-2672.94.s1.12.x.
7. Milnes AS, Stewart I, Clifton-Hadley FA, Davies RH, Newell DG, Sayers AR,
Cheasty T, Cassar C, Ridley A, Cook AJ, Evans SJ, Teale CJ, Smith RP,
McNally A, Toszeghy M, Futter R, Kay A, Paiba GA. 2008. Intestinal
carriage of verocytotoxigenic Escherichia coli O157, Salmonella, thermo-
philic Campylobacter and Yersinia enterocolitica, in cattle, sheep and pigs
at slaughter in Great Britain during 2003. Epidemiol Infect 136:739–751.
https://doi.org/10.1017/S0950268807009223.
8. Acik MN, Cetinkaya B. 2006. Heterogeneity of Campylobacter jejuni and
Campylobacter coli strains from healthy sheep. Vet Microbiol 115:
370–375. https://doi.org/10.1016/j.vetmic.2006.02.014.
9. Mannering SA, West DM, Fenwick SG, Marchant RM, O’Connell K. 2006.
Pulsed-ﬁeld gel electrophoresis of Campylobacter jejuni sheep abortion
isolates. Vet Microbiol 115:237–242. https://doi.org/10.1016/j.vetmic
.2006.01.005.
10. Burrough ER, Sahin O, Plummer PJ, Zhang QJ, Yaeger MJ. 2009. Patho-
genicity of an emergent, ovine abortifacient Campylobacter jejuni clone
orally inoculated into pregnant guinea pigs. Am J Vet Res 70:1269–1276.
https://doi.org/10.2460/ajvr.70.10.1269.
11. Sahin O, Fitzgerald C, Stroika S, Zhao S, Sippy RJ, Kwan P, Plummer PJ,
Han J, Yaeger MJ, Zhang Q. 2012. Molecular evidence for zoonotic
transmission of an emergent highly pathogenic Campylobacter jejuni
clone in the United States. J Clin Microbiol 50:680–687. https://doi.org/
10.1128/JCM.06167-11.
12. Bolton DJ. 2015. Campylobacter virulence and survival factors. Food
Microbiol 48:99–108. https://doi.org/10.1016/j.fm.2014.11.017.
13. Young KT, Davis LM, DiRita VJ. 2007. Campylobacter jejuni: molecular
biology and pathogenesis. Nat Rev Microbiol 5:665–679. https://doi.org/
10.1038/nrmicro1718.
14. Gilbreath JJ, Cody WL, Merrell DS, Hendrixson DR. 2011. Change is good:
variations in common biological mechanisms in the epsilonproteobac-
terial genera Campylobacter and Helicobacter. Microbiol Mol Biol Rev
75:84–132. https://doi.org/10.1128/MMBR.00035-10.
15. Konkel ME, Monteville MR, Rivera-Amill V, Joens LA. 2001. The patho-
genesis of Campylobacter jejuni-mediated enteritis. Curr Issues Intest
Microbiol 2:55–71.
16. Poly F, Guerry P. 2008. Pathogenesis of Campylobacter. Curr Opin Gas-
troenterol 24:27–31. https://doi.org/10.1097/MOG.0b013e3282f1dcb1.
17. Hendrixson DR, DiRita VJ. 2004. Identiﬁcation of Campylobacter jejuni
genes involved in commensal colonization of the chick gastrointestinal
tract. Mol Microbiol 52:471–484. https://doi.org/10.1111/j.1365-2958
.2004.03988.x.
18. Grogono-Thomas R, Dworkin J, Blaser MJ, Newell DG. 2000. Roles of the
surface layer proteins of Campylobacter fetus subsp. fetus in ovine abor-
tion. Infect Immun 68:1687–1691. https://doi.org/10.1128/IAI.68.3.1687
-1691.2000.
19. Wu Z, Sahin O, Shen Z, Liu P, Miller WG, Zhang Q. 2013. Multi-omics
approaches to deciphering a hypervirulent strain of Campylobacter jejuni.
Genome Biol Evol 5:2217–2230. https://doi.org/10.1093/gbe/evt172.
20. Karlyshev AV, Quail MA, Parkhill J, Wren BW. 2013. Unusual features in
organisation of capsular polysaccharide-related genes of C. jejuni strain
X. Gene 522:37–45. https://doi.org/10.1016/j.gene.2013.03.087.
21. Guerry P, Szymanski CM. 2008. Campylobacter sugars sticking out.
Trends Microbiol 16:428–435. https://doi.org/10.1016/j.tim.2008.07.002.
22. Guerry P, Poly F, Riddle M, Maue AC, Chen YH, Monteiro MA. 2012.
Campylobacter polysaccharide capsules: virulence and vaccines. Front
Cell Infect Microbiol 2:7. https://doi.org/10.3389/fcimb.2012.00007.
23. Karlyshev AV, Wren BW. 2001. Detection and initial characterization of
novel capsular polysaccharide among diverse Campylobacter jejuni
strains using alcian blue dye. J Clin Microbiol 39:279–284. https://doi
.org/10.1128/JCM.39.1.279-284.2001.
24. Karlyshev AV, Linton D, Gregson NA, Lastovica AJ, Wren BW. 2000.
Genetic and biochemical evidence of a Campylobacter jejuni capsular
polysaccharide that accounts for Penner serotype speciﬁcity. Mol Micro-
biol 35:529–541. https://doi.org/10.1046/j.1365-2958.2000.01717.x.
25. Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D,
Chillingworth T, Davies RM, Feltwell T, Holroyd S, Jagels K, Karlyshev AV,
Moule S, Pallen MJ, Penn CW, Quail MA, Rajandream MA, Rutherford KM,
van Vliet AH, Whitehead S, Barrell BG. 2000. The genome sequence of
the food-borne pathogen Campylobacter jejuni reveals hypervariable
sequences. Nature 403:665–668. https://doi.org/10.1038/35001088.
26. Poly F, Serichantalergs O, Kuroiwa J, Pootong P, Mason C, Guerry P,
Parker CT. 2015. Updated Campylobacter jejuni capsule PCR multiplex
typing system and its application to clinical isolates from South and
Southeast Asia. PLoS One 10:e0144349. https://doi.org/10.1371/journal
.pone.0144349.
27. Pike BL, Guerry P, Poly F. 2013. Global distribution of Campylobacter
jejuni Penner serotypes: a systematic review. PLoS One 8:e67375. https://
doi.org/10.1371/journal.pone.0067375.
28. Jones MA, Marston KL, Woodall CA, Maskell DJ, Linton D, Karlyshev AV,
Dorrell N, Wren BW, Barrow PA. 2004. Adaptation of Campylobacter jejuni
NCTC11168 to high-level colonization of the avian gastrointestinal tract.
Infect Immun 72:3769–3776. https://doi.org/10.1128/IAI.72.7.3769-3776
.2004.
29. Bacon DJ, Szymanski CM, Burr DH, Silver RP, Alm RA, Guerry P. 2001. A
phase-variable capsule is involved in virulence of Campylobacter jejuni
81-176. Mol Microbiol 40:769–777. https://doi.org/10.1046/j.1365-2958
.2001.02431.x.
30. van Alphen LB, Wenzel CQ, Richards MR, Fodor C, Ashmus RA, Stahl M,
Karlyshev AV, Wren BW, Stintzi A, Miller WG, Lowary TL, Szymanski CM.
2014. Biological roles of the O-methyl phosphoramidate capsule modi-
ﬁcation in Campylobacter jejuni. PLoS One 9:e87051. https://doi.org/10
.1371/journal.pone.0087051.
31. Maue AC, Mohawk KL, Giles DK, Poly F, Ewing CP, Jiao Y, Lee G, Ma Z,
Monteiro MA, Hill CL, Ferderber JS, Porter CK, Trent MS, Guerry P. 2013.
The polysaccharide capsule of Campylobacter jejuni modulates the host
immune response. Infect Immun 81:665–672. https://doi.org/10.1128/
IAI.01008-12.
32. Keo T, Collins J, Kunwar P, Blaser MJ, Iovine NM. 2011. Campylobacter
capsule and lipooligosaccharide confer resistance to serum and cationic
antimicrobials. Virulence 2:30–40. https://doi.org/10.4161/viru.2.1.14752.
33. Monteiro MA, Baqar S, Hall ER, Chen YH, Porter CK, Bentzel DE, Applebee
L, Guerry P. 2009. Capsule polysaccharide conjugate vaccine against
diarrheal disease caused by Campylobacter jejuni. Infect Immun 77:
1128–1136. https://doi.org/10.1128/IAI.01056-08.
34. Burrough ER, Sahin O, Plummer PJ, DiVerde K, Zhang Q, Yaeger MJ. 2010.
Comparison of two commercial ovine Campylobacter vaccines and an
experimental bacterin in a guinea pig model. Am J Vet Res 72:799–805.
https://doi.org/10.2460/ajvr.72.6.799.
35. Karlyshev AV, Champion OL, Churcher C, Brisson JR, Jarrell HC, Gilbert M,
Sahin et al. Infection and Immunity
June 2017 Volume 85 Issue 6 e00001-17 iai.asm.org 14
 o
n
 N
ovem
ber 29, 2017 by IO
W
A STATE UNIVERSITY
http://iai.asm
.org/
D
ow
nloaded from
 
Brochu D, St Michael F, Li J, Wakarchuk WW, Goodhead I, Sanders M,
Stevens K, White B, Parkhill J, Wren BW, Szymanski CM. 2005. Analysis of
Campylobacter jejuni capsular loci reveals multiple mechanisms for the
generation of structural diversity and the ability to form complex hep-
toses. Mol Microbiol 55:90–103. https://doi.org/10.1111/j.1365-2958
.2004.04374.x.
36. Poly F, Serichatalergs O, Schulman M, Ju J, Cates CN, Kanipes M, Mason
C, Guerry P. 2011. Discrimination of major capsular types of Campylo-
bacter jejuni by multiplex PCR. J Clin Microbiol 49:1750–1757. https://
doi.org/10.1128/JCM.02348-10.
37. Wu Z, Periaswamy B, Sahin O, Yaeger M, Plummer P, Zhai W, Shen Z, Dai
L, Chen SL, Zhang Q. 2016. Point mutations in the major outer mem-
brane protein drive hypervirulence of a rapidly expanding clone of
Campylobacter jejuni. Proc Natl Acad Sci U S A 113:10690–10695. https://
doi.org/10.1073/pnas.1605869113.
38. Smith JL. 2002. Campylobacter jejuni infection during pregnancy: long-
term consequences of associated bacteremia, Guillain-Barre syndrome,
and reactive arthritis. J Food Prot 65:696–708. https://doi.org/10.4315/
0362-028X-65.4.696.
39. Blaser MJ, Perez GP, Smith PF, Patton C, Tenover FC, Lastovica AJ, Wang
WI. 1986. Extraintestinal Campylobacter jejuni and Campylobacter coli
infections: host factors and strain characteristics. J Infect Dis 153:
552–559. https://doi.org/10.1093/infdis/153.3.552.
40. Wong A, Lange D, Houle S, Arbatsky NP, Valvano MA, Knirel YA, Dozois
CM, Creuzenet C. 2015. Role of capsular modiﬁed heptose in the viru-
lence of Campylobacter jejuni. Mol Microbiol 96:1136–1158. https://doi
.org/10.1111/mmi.12995.
41. Bachtiar BM, Coloe PJ, Fry BN. 2007. Knockout mutagenesis of the kpsE
gene of Campylobacter jejuni 81116 and its involvement in bacterium-
host interactions. FEMS Immunol Med Microbiol 49:149–154. https://doi
.org/10.1111/j.1574-695X.2006.00182.x.
42. Grant AJ, Coward C, Jones MA, Woodall CA, Barrow PA, Maskell DJ. 2005.
Signature-tagged transposon mutagenesis studies demonstrate the dy-
namic nature of cecal colonization of 2-week-old chickens by Campylo-
bacter jejuni. Appl Environ Microbiol 71:8031–8041. https://doi.org/10
.1128/AEM.71.12.8031-8041.2005.
43. Rose A, Kay E, Wren BW, Dallman MJ. 2012. The Campylobacter jejuni
NCTC11168 capsule prevents excessive cytokine production by dendritic
cells. Med Microbiol Immunol 201:137–144. https://doi.org/10.1007/
s00430-011-0214-1.
44. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R,
Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P. 2001. Dendritic cells
express tight junction proteins and penetrate gut epithelial monolayers
to sample bacteria. Nat Immunol 2:361–367. https://doi.org/10.1038/
86373.
45. Geddes K, Rubino SJ, Magalhaes JG, Streutker C, Le Bourhis L, Cho JH,
Robertson SJ, Kim CJ, Kaul R, Philpott DJ, Girardin SE. 2011. Identiﬁcation
of an innate T helper type 17 response to intestinal bacterial pathogens.
Nat Med 17:837–844. https://doi.org/10.1038/nm.2391.
46. Baig A, McNally A, Dunn S, Paszkiewicz KH, Corander J, Manning G. 2015.
Genetic import and phenotype speciﬁc alleles associated with hyper-
invasion in Campylobacter jejuni. BMC Genomics 16:852. https://doi.org/
10.1186/s12864-015-2087-y.
47. Delong WJ, Jaworski MD, Ward AC. 1996. Antigenic and restriction
enzyme analysis of Campylobacter spp. associated with abortion in
sheep. Am J Vet Res 57:163–167.
48. Williams CE, Renshaw HW, Meinershagen WA, Everson DO, Chamberlain
RK, Hall RF, Waldhalm DG. 1976. Ovine campylobacterosis: preliminary
studies of the efﬁcacy of the in vitro serum bactericidal test as an assay
for the potency of Campylobacter (Vibrio) fetus subsp. intestinalis bacte-
rins. Am J Vet Res 37:409–415.
49. Maue AC, Poly F, Guerry P. 2014. A capsule conjugate vaccine approach
to prevent diarrheal disease caused by Campylobacter jejuni. Hum Vaccin
Immunother 10:1499–1504. https://doi.org/10.4161/hv.27985.
50. Hofreuter D, Tsai J, Watson RO, Novik V, Altman B, Benitez M, Clark C,
Perbost C, Jarvie T, Du L, Galan JE. 2006. Unique features of a highly
pathogenic Campylobacter jejuni strain. Infect Immun 74:4694–4707.
https://doi.org/10.1128/IAI.00210-06.
51. Jeon B, Muraoka W, Scupham A, Zhang Q. 2009. Roles of lipooligosac-
charide and capsular polysaccharide in antimicrobial resistance and
natural transformation of Campylobacter jejuni. J Antimicrob Chemother
63:462–468. https://doi.org/10.1093/jac/dkn529.
52. Wittwer M, Keller J, Wassenaar TM, Stephan R, Howald D, Regula G,
Bissig-Choisat B. 2005. Genetic diversity and antibiotic resistance pat-
terns in a Campylobacter population isolated from poultry farms in
Switzerland. Appl Environ Microbiol 71:2840–2847. https://doi.org/10
.1128/AEM.71.6.2840-2847.2005.
53. Han J, Sahin O, Barton YW, Zhang Q. 2008. Key role of Mfd in the
development of ﬂuoroquinolone resistance in Campylobacter jejuni.
PLoS Pathog 4:e1000083. https://doi.org/10.1371/journal.ppat.1000083.
54. Oakland M, Jeon B, Sahin O, Shen ZQ, Zhang QJ. 2011. Functional charac-
terization of a lipoprotein-encoding operon in Campylobacter jejuni. PLoS
One 6:e20084. https://doi.org/10.1371/journal.pone.0020084.
55. Yao R, Alm RA, Trust TJ, Guerry P. 1993. Construction of new Campylo-
bacter cloning vectors and a new mutational cat cassette. Gene 130:
127–130. https://doi.org/10.1016/0378-1119(93)90355-7.
56. Blaser MJ, Duncan DJ, Warren GH, Wang WL. 1983. Experimental Cam-
pylobacter jejuni infection of adult mice. Infect Immun 39:908–916.
57. Sahin O, Zhang Q, Meitzler JC, Harr BS, Morishita TY, Mohan R. 2001.
Prevalence, antigenic speciﬁcity, and bactericidal activity of poultry
anti-Campylobacter maternal antibodies. Appl Environ Microbiol 67:
3951–3957. https://doi.org/10.1128/AEM.67.9.3951-3957.2001.
Role of Capsule in Campylobacter Pathogenesis Infection and Immunity
June 2017 Volume 85 Issue 6 e00001-17 iai.asm.org 15
 o
n
 N
ovem
ber 29, 2017 by IO
W
A STATE UNIVERSITY
http://iai.asm
.org/
D
ow
nloaded from
 
